Mark Jacobstein
General Partner at Near Horizon
Stanford, California
Overview
Work Experience
Co-founder and General Partner
2023 - Current
Near Horizon is pioneering a new approach to venture building. We partner with entrepreneurs at company formation to build AI-powered companies, providing both capital and hands-on help
Venture Builder
2023
Venture Builder
2023
Co-Founder and President
2023
Board Member
2018
Luminopia develops a new class of treatments for significant neuro-visual disorders.
Raised $33,150,000.00 from Broadfin Advisors, U.S. Venture Partners, Shangbay Capital and The Vertical Group.
Board Member
2020
Odin is intended for use on common mobile smartphones.
Executive Business Advisor and stay-at-home dad
2023 - 2023
Executive Business Advisor at Immunai
2022 - 2023
Part-time business advisor for Immunai and stay-at-home dad.
Chief Business Officer
2020 - 2022
Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.
Raised $295,000,000.00 from Piedmont Capital Investments, Alexandria Venture Investments, Koch Disruptive Technologies, 8VC, ICon, Meron Capital and Talos VC.
Chief User Engagement Officer
2015 - 2019
Guardant Health (https://www.guardanthealth.com/) is the world’s leader in “blood biopsies”: blood tests that track tumor genomics and identify treatment options. As CUEO I was responsible for ensuring that Guardant's products are engaging for all of our customers – not only our physicians, but also our patients, their families, advocates, and anyone whose life is touched by cancer. I also oversaw our marketing department, working to advance our brand as the world’s leader in liquid biopsies, identifying new products for the product portfolio, and supporting sales in their efforts to reach the oncology community.
Board Member
2011 - 2017
Education
B.A.
1988 - 1992